Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07729397Phase 1Not Yet Recruiting
Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveDiffuse Large B-Cell Lymphoma (DLBCL)+2 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Premal Lulla, MD

The Methodist Hospital Research Institute

Similar
3 trials

Shared therapeutic areas:

Anaplastic Large Cell Lymphoma, ALK-negativeAnaplastic Large Cell Lymphoma, ALK-PositiveHodgkin Disease+2 more

Worked with same sponsors:

Baylor College of MedicineThe Methodist Hospital Research Institute
Collaborated on 1 trial
Similarity Score54%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Hodgkin DiseaseAnaplastic Large Cell Lymphoma, ALK-negativeAnaplastic Large Cell Lymphoma, ALK-Positive+1 more

Worked with same sponsors:

Baylor College of MedicineThe Methodist Hospital Research Institute
Similarity Score24%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Anaplastic Large Cell Lymphoma, ALK-PositiveLymphoma, Large B-Cell, DiffuseHodgkin Disease

Worked with same sponsors:

Baylor College of Medicine
Similarity Score18%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Baylor College of Medicine
Similarity Score18%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, Diffuse
Similarity Score12%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse
Similarity Score12%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Large B-Cell, Diffuse
Similarity Score12%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral
Similarity Score12%

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related
14 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHodgkin Disease
Similarity Score12%

Ye Guo, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseHodgkin Disease
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07729397Phase 1PrincipalInvestigator

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveDiffuse Large B-Cell Lymphoma (DLBCL)+2 more
Not Yet Recruiting

All 1 trials loaded